News

Radiotherapy plus chemotherapy drive risk of pancreatic cancer in HL patients

Publish date: August 13, 2014

 

FROM ANNALS OF ONCOLOGY

References

dbrunk@frontlinemedcom.com

On Twitter @dougbrunk

Pages

Recommended Reading

Everolimus fails to improve HCC survival
MDedge Hematology and Oncology
Angiogenic kinase inhibitor receives orphan drug designation for hepatocellular carcinoma
MDedge Hematology and Oncology
Vary CRC screening by age, sex, race, ethnicity?
MDedge Hematology and Oncology
TCGA investigators propose four subtypes of gastric cancer
MDedge Hematology and Oncology
Stage esophageal cancer after neoadjuvant chemo
MDedge Hematology and Oncology
Gut bacteria populations may predict colon cancers
MDedge Hematology and Oncology
Flexible sigmoidoscopy screening reduces colorectal cancer, mortality
MDedge Hematology and Oncology
Medical consultation rates for surgical cases vary
MDedge Hematology and Oncology
Benefits outweigh harms of aspirin therapy
MDedge Hematology and Oncology
FDA okays DNA stool test for CRC screening; Medicare considers coverage
MDedge Hematology and Oncology